No abstract available
Keywords:
DLBCL; TIL; TIL-B; TME; clinical decision support tool; flow cytometry; prognosis; tumor-infiltrating lymphocytes.
Publication types
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Flow Cytometry* / methods
-
Humans
-
Lymphocytes, Tumor-Infiltrating* / immunology
-
Lymphocytes, Tumor-Infiltrating* / metabolism
-
Lymphoma, Large B-Cell, Diffuse* / immunology
-
Lymphoma, Large B-Cell, Diffuse* / mortality
-
Prognosis
Grants and funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The article processing cost is supported by the Natural Science Foundation of Shandong Province (ZR2022MH310, ZR2023MH376).